Compound ID | 1277
Class: Bacteriophage lysin
| Spectrum of activity: | Gram-positive |
| Details of activity: | P128 is a chimeric recombinant ectolysin (phage lysin involved in cleaving the peptidoglycan from outside the bacterium during DNA injection) with potent anti-Staphylococcus activity. |
| Institute where first reported: | Gangagen Biotechnologies Pvt Ltd |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |